These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 21349948)
1. A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma. Kozyreva ON; Chi D; Clark JW; Wang H; Theall KP; Ryan DP; Zhu AX Oncologist; 2011; 16(3):310-8. PubMed ID: 21349948 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, treatment patterns and survival outcome of hepatocellular carcinoma patients aged 70 years or older: a single-center retrospective study from China. Fan C; Jin G; Sun C; Ma D; Chen C; Qiao P; Wu D Aging Clin Exp Res; 2014 Apr; 26(2):123-30. PubMed ID: 24129805 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S; J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients. Saneto H; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Kumada H J Gastroenterol; 2008; 43(12):975-81. PubMed ID: 19107342 [TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years]. Fernández-Ruiz M; Guerra-Vales JM; Llenas-García J; Colina-Ruizdelgado F Rev Esp Enferm Dig; 2008 Oct; 100(10):625-31. PubMed ID: 19119788 [TBL] [Abstract][Full Text] [Related]
6. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response. Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617 [TBL] [Abstract][Full Text] [Related]
7. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection. Aljumah AA; Kuriry H; Faisal N; Alghamdi H Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991 [TBL] [Abstract][Full Text] [Related]
9. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma. Tanase AM; Dumitrascu T; Dima S; Grigorie R; Marchio A; Pineau P; Popescu I Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):162-72. PubMed ID: 24686543 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinical characteristics of non-B non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma and prognosis in Uighur patients]. Zhang R; Zhou S; Xiao L; Zhang H; Tulahong A; Zhang Y; Wen H; Bao Y Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):540-4. PubMed ID: 26463333 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. El-Serag HB; Kramer J; Duan Z; Kanwal F J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447 [TBL] [Abstract][Full Text] [Related]
12. Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis. Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI Medicine (Baltimore); 2014 Dec; 93(28):e264. PubMed ID: 25526453 [TBL] [Abstract][Full Text] [Related]
13. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience. Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078 [TBL] [Abstract][Full Text] [Related]
15. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. Lewin M; Gelu-Simeon M; Ostos M; Boufassa F; Sobesky R; Teicher E; Meyer L; Fontaine H; Salmon-Céron D; Samuel D; Seror O; Trinchet JC; Duclos-Vallée JC Radiology; 2015 Nov; 277(2):443-53. PubMed ID: 25961631 [TBL] [Abstract][Full Text] [Related]
16. Hepatic resection for hepatocellular carcinoma in elderly patients. Yeh CN; Lee WC; Jeng LB; Chen MF Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868 [TBL] [Abstract][Full Text] [Related]
17. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry. Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276 [TBL] [Abstract][Full Text] [Related]
18. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487 [TBL] [Abstract][Full Text] [Related]
19. Characteristics and Outcomes of Extreme Elderly Patients With Hepatocellular Carcinoma in South Korea. Seo JH; Kim DH; Cho E; Jun CH; Park SY; Cho SB; Park CH; Kim HS; Choi SK; Rew JS In Vivo; 2019; 33(1):145-154. PubMed ID: 30587615 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the clinicopathological features of hepatocellular carcinoma in elderly patients. Jing-Lin X; Sharma D; Bing-Hui Y; Bo-Heng Z; Zeng-Chen M; Zhi-Quan W; Jia F; Xin ZD; Lun-Xiu Q; Zhao-You X JNMA J Nepal Med Assoc; 2008; 47(171):132-5. PubMed ID: 19079378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]